Marcos Garcia-Fuentes
TitleCited byYear
Transmucosal macromolecular drug delivery
C Prego, M Garcia, D Torres, MJ Alonso
Journal of Controlled Release 101 (1-3), 151-162, 2005
3412005
Design of lipid nanoparticles for the oral delivery of hydrophilic macromolecules
M Garcıa-Fuentes, D Torres, MJ Alonso
Colloids and Surfaces B: Biointerfaces 27 (2-3), 159-168, 2003
2622003
Chitosan-based drug nanocarriers: where do we stand?
M Garcia-Fuentes, MJ Alonso
Journal of Controlled Release 161 (2), 496-504, 2012
2612012
Nanoparticles for nasal vaccination
N Csaba, M Garcia-Fuentes, MJ Alonso
Advanced drug delivery reviews 61 (2), 140-157, 2009
2432009
A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly (ethylene glycol) as carriers for oral calcitonin delivery
M Garcia-Fuentes, C Prego, D Torres, MJ Alonso
European journal of pharmaceutical sciences 25 (1), 133-143, 2005
1872005
Optimization strategies for electrospun silk fibroin tissue engineering scaffolds
AJ Meinel, KE Kubow, E Klotzsch, M Garcia-Fuentes, ML Smith, V Vogel, ...
Biomaterials 30 (17), 3058-3067, 2009
1802009
New surface-modified lipid nanoparticles as delivery vehicles for salmon calcitonin
M Garcia-Fuentes, D Torres, MJ Alonso
International journal of pharmaceutics 296 (1-2), 122-132, 2005
1722005
Silk fibroin/hyaluronan scaffolds for human mesenchymal stem cell culture in tissue engineering
M Garcia-Fuentes, AJ Meinel, M Hilbe, L Meinel, HP Merkle
Biomaterials 30 (28), 5068-5076, 2009
1292009
A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin
F Maestrelli, M Garcia-Fuentes, P Mura, MJ Alonso
European Journal of Pharmaceutics and Biopharmaceutics 63 (2), 79-86, 2006
1192006
A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides
A Trapani, A Lopedota, M Franco, N Cioffi, E Ieva, M Garcia-Fuentes, ...
European Journal of Pharmaceutics and Biopharmaceutics 75 (1), 26-32, 2010
1162010
Physicochemical behavior and cytotoxic effects of p (methacrylic acid–g-ethylene glycol) nanospheres for oral delivery of proteins
M Torres-Lugo, M García, R Record, NA Peppas
Journal of controlled release 80 (1-3), 197-205, 2002
1142002
The performance of nanocarriers for transmucosal drug delivery
N Csaba, M Garcia-Fuentes, MJ Alonso
Expert opinion on drug delivery 3 (4), 463-478, 2006
1032006
Nanoparticles as protein and gene carriers to mucosal surfaces
M De La Fuente, N Csaba, M Garcia-Fuentes, MJ Alonso
Future Medicine Ltd 3 (6), 845-857, 2008
902008
Design and characterization of a new drug nanocarrier made from solid–liquid lipid mixtures
M Garcia-Fuentes, MJ Alonso, D Torres
Journal of colloid and interface science 285 (2), 590-598, 2005
892005
Application of NMR spectroscopy to the characterization of PEG-stabilized lipid nanoparticles
M Garcia-Fuentes, D Torres, M Martín-Pastor, MJ Alonso
Langmuir 20 (20), 8839-8845, 2004
892004
pH‐Sensitive hydrogels as gastrointestinal tract absorption enhancers: transport mechanisms of salmon calcitonin and other model molecules using the Caco‐2 cell model
M Torres‐Lugo, M García, R Record, NA Peppas
Biotechnology progress 18 (3), 612-616, 2002
872002
Novel drug nanocarriers combining hydrophilic cyclodextrins and chitosan
A Trapani, M Garcia-Fuentes, MJ Alonso
Nanotechnology 19 (18), 185101, 2008
672008
Protein delivery based on uncoated and chitosan-coated mesoporous silicon microparticles
E Pastor, E Matveeva, A Valle-Gallego, FM Goycoolea, M Garcia-Fuentes
Colloids and Surfaces B: Biointerfaces 88 (2), 601-609, 2011
632011
Hyaluronic acid/Chitosan nanoparticles as delivery vehicles for VEGF and PDGF-BB
Y Parajó, I d’Angelo, A Welle, M Garcia-Fuentes, MJ Alonso
Drug delivery 17 (8), 596-604, 2010
612010
Systemic heparin delivery by the pulmonary route using chitosan and glycol chitosan nanoparticles
A Trapani, S Di Gioia, N Ditaranto, N Cioffi, FM Goycoolea, A Carbone, ...
International journal of pharmaceutics 447 (1-2), 115-123, 2013
582013
The system can't perform the operation now. Try again later.
Articles 1–20